Categories
Financial

Perhaps Turning Point Therapeutics, Inc. (TPTX) Has Found Some Support In The Market Place

Turning Point Therapeutics, Inc. (TPTX) has seen some recent activity in the marketplace and its shares finished trading at $101.28 yesterday. Investors are starting to take notice of TPTX as the shares traded as high as $104.42 and as low as $100.22 in the previous market trading session.

Turning Point Therapeutics, Inc. (TPTX) average trading volume is 432.34K. However, in the previous market trading session Turning Point Therapeutics, Inc. (TPTX) exchanged 669,652 shares. The 1st downside support level on TPTX is $100.12 and the 1st resistance level on TPTX is $124.99. TPTX fifty day moving average is $95.02 and TPTX 200-day moving average is $70.62.

Turning Point Therapeutics, Inc. (TPTX) most current performance has been shown by the recent movement in TPTX shares. TPTX has performed 15.93% over the past month, TPTX has performed 70.99% over the past quarter and TPTX has shown 165.20% over the past 365 days. Turning Point Therapeutics, Inc. (TPTX) has a 12 month range of $31.30 to $122.85. Turning Point Therapeutics, Inc. (TPTX) is trading 223.53% from its 12 month low and -17.56% from its 12 month high. Turning Point Therapeutics, Inc. (TPTX) is showing a 12.19% short float showing the amount short in the float.

TPTX has 38.60M shares outstanding and 30.83M shares in the float. Turning Point Therapeutics, Inc. (TPTX) at this time has a market cap of $4.24B and income of -133.70M. The EPS next quarter for TPTX is -0.55 and projected EPS next year is -2.60%. The market cap of Turning Point Therapeutics, Inc. (TPTX) at $4.24B represents how many Investors own shares of TPTX and is based off the last price ($101.28) of TPTX and the amount of shares outstanding (38.60M) with Turning Point Therapeutics, Inc. (TPTX).

Turning Point Therapeutics, Inc. (TPTX) has total cash (mrq) of 710.43M, total cash per share (mrq) of 16.85, total debt of TPTX rests at 4.46M and total debt/equity (mrq) is 0.63. . Turning Point Therapeutics, Inc. (TPTX) operating cash flow (ttm) is -81.78M, TPTX leveraged free cash flow (ttm) is -15.12M.

TPTX is trading -2.35% below (bearish) its SMA20, 14.23% above (bullish) its SMA50 and 56.84% above (bullish) its SMA200.

Leave a Reply

Your email address will not be published. Required fields are marked *